Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study
- Resource Type
- Article
- Source
- In
Journal of Diabetes and Its Complications September 2021 35(9) - Subject
- Language
- ISSN
- 1056-8727